114 results
Page 2 of 6
8-K
EX-99.2
4r23 7bpw
3 Nov 21
Lumos Pharma Reports Third Quarter 2021 Financial Results and Provides Clinical Updates
4:11pm
8-K
EX-99.2
ri8ih7o73dyft6
5 Aug 21
Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
4:27pm
8-K
EX-99.1
56kysfv3q7f0bre0
2 Aug 21
Lumos Pharma Announces the Promotion of COO and Chief Scientific Officer, John McKew, PhD, to President
9:22am
8-K
EX-99.2
bploixl m3og6
5 May 21
Lumos Pharma Reports First Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
4:28pm
8-K
EX-99.1
asvj 0ntcj1sjn
21 Apr 21
Lumos Pharma Announces Retirement of Carl Langren and Names Lori Lawley Chief Financial Officer in Planned Succession
4:36pm
8-K
EX-99.2
adetqiuq8rgi5au0m
13 Aug 20
Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
4:36pm
8-K/A
yvxkhzanzu83p4u1
1 Jun 20
Other Events
12:00am
8-K
EX-99.2
dj4 x4mxym2rx7q8ic
28 May 20
Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
4:41pm
8-K
EX-99.1
qtfsqaobk9d98w
24 Apr 20
Other Events
10:04am
8-K
EX-99.1
edbfflb8agc05iw3rd
2 Apr 20
Departure of Directors or Certain Officers
4:32pm
8-K
EX-10.3
gspaiemt
18 Mar 20
NewLink Genetics Stockholders Approve Merger with Lumos Pharma
4:37pm
8-K
EX-10.1
8n2gtjnxm950
18 Mar 20
NewLink Genetics Stockholders Approve Merger with Lumos Pharma
4:37pm
DEFA14A
5nne x1gvl9uflp
6 Mar 20
Additional proxy soliciting materials
8:14am